(Q69040306)

English

Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142)

scientific article published on 01 January 1974

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 September 2019

title

Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142) (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

1 reference

1 reference

H. S. Schwartz

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4521481

retrieved

30 January 2023

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

4521481

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4521481

retrieved

30 January 2023

publication date

1 January 1974

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 September 2019

published in

Cancer chemotherapy reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 September 2019

volume

58

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 September 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 September 2019

page(s)

55-62

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 September 2019

Identifiers

PubMed publication ID

4521481

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4521481

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4521481%20AND%20SRC:MED&resulttype=core&format=json

(Q69040306)

Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)